🎥ICYMI | #AntimicrobialStewardship in Critical Care Units
ISAC President Prof. Souha Kanj & renowned international experts explore cutting-edge strategies to optimise #antimicrobial use in ICUs in this webinar by ISAC & APUA
youtu.be/W68zNURKPjw
#IDSky
@souhakanj.bsky.social @esgap.bsky.social

Huge thanks to @esgap.bsky.social for the travel grant that allowed me to attend @escmid.bsky.social #ESCMIDGlobal and present my poster this Saturday. Grateful for the chance to share our work and connect with the amazing ID community!

🦠 Meet us in a few minutes at 1:30 pm in Schubert 1+2 for ESGAP Business Meeting @escmid.bsky.social @taescmid.bsky.social @eucic.bsky.social

We will talk about our ESGAP aims, members, activities in training, research, collaborations and future projects

You are all welcome

Nighttrain journey to Vienna for #ESCMIDGlobal. Looking forward to five days of discussing all things infectiousdiseases & clinical microbiology!🦠 #IDSky @escmid.bsky.social @taescmid.bsky.social @esgap.bsky.social

🔥Do not hesitate to join ESGAP (study group on antimicrobial stewardship) business meeting in a few minutes Schubert 1+2 @escmid.bsky.social @esgap.bsky.social
@spilf.bsky.social @rejif-spilf.bsky.social

#ESCMIDGlobal 2025 is dedicated to making a healthier tomorrow! There are so many new activities that we want to share with you but here are just a few of the highlights.

Register before 05 March to avoid late fees!

www.linkedin.com/posts/escmid...
#ForAHealthierTomorrow #IDSky #clinmicro

@escmid.bsky.social published their planned guidelines for development from 2025-2029 in @cmicomms.bsky.social #IDSky

What upcoming ESCMID guidelines are you most excited about in the next 5 years?!

Mine? Invasive Strep & Catheter Infxns!

www.clinicalmicrobiologyandinfection.com/article/S119...

🔥 @esgap.bsky.social commentary published in
@cmijournal.bsky.social @escmid.bsky.social

Enhancing Antimicrobial stewardship: recommendations to support implementation of the 2024 UNGA Political Declaration on Antimicrobial Resistance

www.clinicalmicrobiologyandinfection.com/article/S119...

🔥 @hopitalbichat.bsky.social data on long term outcomes patients with Central Nervous System tuberculosis

76 patients, 2 years from diagnosis: 40% persistent motor deficit, 12% death

Published in @cmijournal.bsky.social @escmid.bsky.social

www.clinicalmicrobiologyandinfection.com/article/S119...

#AMR is a global threat and the only way to address it is to attack from all sides. That's the purpose of the AMR Science-Policy Forum, to connect policymakers and scientists together so that we can join forces #ForAHealthierTomorrow.

ow.ly/RPoC50V7A0C
#ESCMIDGlobal #IDSky #clinmicro

🔥The @escmid.bsky.social Study Group for Antimicrobial Stewardship (ESGAP) has joined BSky!

We organize webinars, write newsletters, promote European research on AMS, participate in the AMS certificate and more

Visit www.escmid.org/esgap/ to find more

Also on www.linkedin.com/groups/90724...

🔥The @escmid.bsky.social Study Group for Antimicrobial Stewardship (ESGAP) has joined BSky!

We organize webinars, write newsletters, promote European research on AMS, participate in the AMS certificate and more

Visit www.escmid.org/esgap/ to find more

Also on www.linkedin.com/groups/90724...